6CM
APYX icon

683 Capital Management’s Apyx Medical APYX Stock Holding History

683 Capital Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,000
Closed -$73.8K – 161
2026
Q1 		$73.8K Sell
20,000
-104,506
-84% -$391K ﹤0.01% 223
2025
Q4 		$436K Buy
+124,506
New +$434K 0.02% 202

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

683 Capital Management's APYX Position: Q2 2026 in Review

683 Capital Management sold out of Apyx Medical (APYX) in Q2 2026, closing a stake of 20,000 shares — an estimated $73.8K sold.

683 Capital Management first reported a position in APYX in Q4 2025 and held it in 2 quarters. The position peaked at $436K in Q4 2025. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • 683 Capital Management reported no remaining Apyx Medical position as of Q2 2026 after selling out during the quarter.
  • 683 Capital Management sold 20,000 Apyx Medical shares in Q2 2026, an estimated $73.8K.
  • 683 Capital Management first reported a position in Apyx Medical in Q4 2025 and held it in 2 quarters.
  • 683 Capital Management's Apyx Medical position peaked at $436K in Q4 2025.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.